Estrogen effects on the forced swim test differ in two outbred rat strains

Physiology and Behavior

Volumn 106, Issue 2, 2012, Pages 81-86

  Koss, Wendy A ^a   Einat, Haim ^a   Schloesser, Robert J ^a   Manji, Husseini K ^a   Rubinow, David R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Depression; Estrogen; Estrogen receptors; Forced swim test; Strain differences

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPRESSION; FEMALE; FORCED SWIMMING TEST; FRONTAL CORTEX; HIPPOCAMPUS; MOOD; MOOD DISORDER; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

ANIMALS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; IMMOBILITY RESPONSE, TONIC; RATS; RATS, LONG-EVANS; RATS, WISTAR; SPECIES SPECIFICITY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84856335781     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.01.004     Document Type: Article

References (56)

1. Schmidt P.J., Nieman L.K., Danaceau M.A., Adams L.F., Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998, 338:209-216.
2. Backstrom T., Sanders D., Leask R., Davidson D., Warner P., Bancroft J. Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med 1983, 45:503-507.
3. Rubinow D.R., Hoban M.C., Grover G.N., Galloway D.S., Roy-Byrne P., Andersen R., et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 1988, 158:5-11.
4. Bloch M., Schmidt P.J., Danaceau M., Murphy J., Nieman L., Rubinow D.R. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000, 157:924-930.
5. Cohen H., Zohar J., Gidron Y., Matar M.A., Belkind D., Loewenthal U., et al. Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats. Biol Psychiatry 2006, 59:1208-1218.
6. Suzuki T., George F.R., Meisch R.A. Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains. J Pharmacol Exp Ther 1988, 245:164-170.
7. Gould T.D., O'Donnell K.C., Picchini A.M., Manji H.K. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 2007, 32:1321-1333.
8. Hiscock K., Linde J., Einat H. Black Swiss mice as a new animal model for mania: a preliminary study. J Med Biol Sci 2007, 1.
9. Vit J.P., Clauw D.J., Moallem T., Boudah A., Ohara P.T., Jasmin L. Analgesia and hyperalgesia from CRF receptor modulation in the central nervous system of Fischer and Lewis rats. Pain 2006, 121:241-260.
10. Harvell D.M., Strecker T.E., Tochacek M., Xie B., Pennington K.L., McComb R.D., et al. Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc Natl Acad Sci U S A 2000, 97:2779-2784.
11. Bailey J.A., Nephew K.P. Strain differences in tamoxifen sensitivity of Sprague-Dawley and Fischer 344 rats. Anticancer Drugs 2002, 13:939-947.
12. Morgan M.A., Pfaff D.W. Estrogen's effects on activity, anxiety, and fear in two mouse strains. Behav Brain Res 2002, 132:85-93.
13. Walf A.A., Frye C.A. Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model. Gend Med 2009, 6:300-311.
14. Estrada-Camarena E., Fernandez-Guasti A., Lopez-Rubalcava C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology 2003, 28:830-838.
15. Rachman I.M., Unnerstall J.R., Pfaff D.W., Cohen R.S. Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test. Proc Natl Acad Sci U S A 1998, 95:13941-13946.
16. Galea L.A., Wide J.K., Barr A.M. Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res 2001, 122:1-9.
17. Walf A.A., Frye C.A. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006, 31:1097-1111.
18. Donner N., Handa R.J. Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 2009, 163:705-718.
19. Hughes Z.A., Liu F., Platt B.J., Dwyer J.M., Pulicicchio C.M., Zhang G., et al. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacology 2008, 54:1136-1142.
20. Walf A.A., Frye C.A. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 2007, 86:407-414.
21. Rocha B.A., Fleischer R., Schaeffer J.M., Rohrer S.P., Hickey G.J. 17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology (Berl) 2005, 179:637-643.
22. Walf A.A., Rhodes M.E., Frye C.A. Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test. Pharmacol Biochem Behav 2004, 78:523-529.
23. Mill J., Kiss E., Baji I., Kapornai K., Daroczy G., Vetro A., et al. International Consortium for Childhood-Onset Mood Disorders. Association study of the estrogen receptor alpha gene (ESR1) and childhood-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1323-1326.
24. Perlman W.R., Tomaskovic-Crook E., Montague D.M., Webster M.J., Rubinow D.R., Kleinman J.E., et al. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness. Biol Psychiatry 2005, 58:812-824.
25. Tejani-Butt S., Kluczynski J., Pare W.P. Strain-dependent modification of behavior following antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:7-14.
26. Lopez-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 2000, 22:191-199.
27. Porsolt R.D., Bertin A., Jalfre M. "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 1978, 51:291-294.
28. Dohanich G.P. Gonadal steroids, learning, and memory. Horm Brain Behav 2002, 2:265-327.
29. Keenan P.A., Ezzat W.H., Ginsburg K., Moore G.J. Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 2001, 26:577-590.
30. Krishnan V., Nestler E.J. Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 2010, 167:1305-1320.
31. Einat H., Clenet F., Shaldubina A., Belmaker R.H., Bourin M. The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors. Behav Brain Res 2001, 118:77-83.
32. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
33. Detke M.J., Johnson J., Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 1997, 5:107-112.
34. Drugan R.C., Skolnick P., Paul S.M., Crawley J.N. A pretest procedure reliably predicts performance in two animal models of inescapable stress. Pharmacol Biochem Behav 1989, 33:649-654.
35. Cryan J.F., Page M.E., Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 2005, 182:335-344.
36. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995, 121:66-72.
37. Koss W.A., Gehlert D.R., Shekhar A. Different effects of subchronic doses of 17-beta estradiol in two ethologically based models of anxiety utilizing female rats. Horm Behav 2004, 46:158-164.
38. Stoffel E.C., Craft R.M. Ovarian hormone withdrawal-induced "depression" in female rats. Physiol Behav 2004, 83:505-513.
39. Schneider T., Popik P. Increased depressive-like traits in an animal model of premenstrual irritability. Horm Behav 2007, 51:142-148.
40. Marvan M.L., Santana S., Chavez Chavez L., Bertran M. Inescapable shocks accentuate fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Arch Med Res 1997, 28:369-372.
41. Raap D.K., Van de Kar L.D. Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci 1999, 65:1217-1235.
42. Osterlund M.K., Hurd Y.L. Acute 17 beta-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Brain Res Mol Brain Res 1998, 55:169-172.
43. Chang A.S., Chang S.M. Nongenomic steroidal modulation of high-affinity serotonin transport. Biochim Biophys Acta 1999, 1417:157-166.
44. Bethea C.L., Gundlah C., Mirkes S.J. Ovarian steroid action in the serotonin neural system of macaques. Novartis Found Symp 2000, 230:112-130. [discussion 130-3].
45. Sumner B.E., Fink G. Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain. Brain Res Mol Brain Res 1998, 59:205-214.
46. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
47. Massou J.M., Trichard C., Attar-Levy D., Feline A., Corruble E., Beaufils B., et al. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology (Berl) 1997, 133:99-101.
48. Lucki I., Singh A., Kreiss D.S. Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 1994, 18:85-95.
49. Pinna G., Costa E., Guidotti A. Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. Proc Natl Acad Sci U S A 2005, 102:2135-2140.
50. Ma S., Wu J., Feng Y., Chen B. Elevated estrogen receptor expression in hypothalamic preoptic area decreased by electroacupuncture in ovariectomized rats. Neurosci Lett 2011, 494:109-113.
51. Yamada S., Noguchi D., Ito H., Yamanouchi K. Sex and regional differences in decrease of estrogen receptor alpha-immunoreactive cells by estrogen in rat hypothalamus and midbrain. Neurosci Lett 2009, 463:135-139.
52. Yuri K., Kawata M. The effect of estrogen on the estrogen receptor-immunoreactive cells in the rat medial preoptic nucleus. Brain Res 1991, 548:50-54.
53. Bohacek J., Daniel J.M. The ability of oestradiol administration to regulate protein levels of oestrogen receptor alpha in the hippocampus and prefrontal cortex of middle-aged rats is altered following long-term ovarian hormone deprivation. J Neuroendocrinol 2009, 21:640-647.
54. Li X., Schwartz P.E., Rissman E.F. Distribution of estrogen receptor-beta-like immunoreactivity in rat forebrain. Neuroendocrinology 1997, 66:63-67.
55. Snyder M.A., Smejkalova T., Forlano P.M., Woolley C.S. Multiple ERbeta antisera label in ERbeta knockout and null mouse tissues. J Neurosci Methods 2010, 188:226-234.
56. Pawluski J.L., Barakauskas V.E., Galea L.A. Pregnancy decreases oestrogen receptor alpha expression and pyknosis, but not cell proliferation or survival, in the hippocampus. J Neuroendocrinol 2010, 22:248-257.